Description
Centaur introduced Woxheal, a new chemical entity (NCE), with German collaboration, for the first time in the world, in India. Centaur conducted phase II and III clinical trials in India for Woxheal and then developed the API and formulations in house. Woxheal treats diabetic foot ulcer, which is an unmet need, and helps save precious limbs from amputation.